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ABSTRACT  
 
Objective: To conduct a comprehensive review and meta-analysis of the effectiveness of 
meditation on a variety of asthma outcomes.  
 
Methods: We searched MEDLINE, EMBASE, CINAHL, PsycINFO and AMED in June 2016 
to identify randomised controlled trials (RCTs) investigating the effectiveness of meditation in 
adults with asthma. No restriction was put on language or year of publication. Study quality 
was assessed using The Cochrane Risk of Bias Assessment Tool. Meta-analysis was carried 
out using RevMan 5.3.  
 
Results: Four RCTS involving 201 patients met the inclusion criteria. Quality of studies was 
inconsistent with only one study reporting adequate allocation concealment. Disease-specific 
quality of life was assessed in two trials; a pooled result involving 62 intervention and 65 
control participants indicated a significant improvement in quality of life in the meditation 
group compared to the control group (SMD 0.40, 95% CI 0.05 to 0.76). A pooled result from 
all four studies indicated the uncertain effect of meditation in forced expiratory volume in one 
second (FEV1) (SMD -0.67, 95% CI -2.17 to 0.82). Results from the individual trials suggest 
that meditation may be helpful in reducing perceived stress and the use of short-term rescue 
medication. 
 
Conclusion: Our review suggests that there is some evidence that meditation is beneficial 
in improving quality of life in asthma patients. As two out of four studies in our review were of 
poor quality, further trials with better methodological quality are needed to support or refute 
this finding. 
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BACKGROUND:  Asthma is a chronic respiratory disease that affects 334 million people 
worldwide. The disease is the 14th most important disorder in terms of the extent and 
duration of disability globally (1). Asthma imposes significant economic burden with an  
estimated annual cost of $56 billion in the USA (2007 estimates), and €19.3 billion among 
Europeans aged from 15 to 64 years (2011 estimates) (1). In Asian-Pacific countries like 
Vietnam and Hong Kong, the sum of direct and indirect costs of asthma per person per year 
was estimated to be $184  and $1,189  respectively (in 2000 US dollars) (1). Despite a 
range of pharmacological treatments for asthma, many patients still experience residual and 
troublesome symptoms that adversely affect their quality of life. Therefore, patients with 
asthma often seek complementary treatment strategies that may enhance their 
pharmacological asthma treatment regimens.  
 
Complementary and Alternative Medicine (CAM) is widely used by patients with asthma, the 
prevalence rates ranging from 4% to 79% (2). Studies examining the effectiveness of CAM 
as a treatment modality for asthma seem to adopt the approach of using CAM techniques 
as an adjunct to conventional medication, rather than an alternative to it (3, 4). Evidence 
suggests that concern about the adverse effects of orthodox asthma treatments and desire 
for greater self-care with a more holistic approach are the main reasons behind CAM use 
(5) (6) (7). The extent of CAM use has been acknowledged in BTS guidelines which 
recommend that health care practitioners should be aware of the frequent use of CAM 
amongst patients with asthma and should enquire about its use (8).  This may assist health 
care providers to engage actively with their patient about overall asthma management, thus 
leading to better health outcomes. The increasing popularity of CAM use in asthma 
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necessitates the investigation of effectiveness and safety of such therapies in order to 
identify and implement evidence-based CAM approaches in the management of asthma.  
 
Stress is linked with asthma, both as a precursor or as an outcome (9-11).  Recent studies 
have reported strong associations between stress and asthma incidence, hospitalisation 
and the use of asthma medication (10, 12). Therefore, interventions aimed at reducing 
stress may have a positive impact on patients’ quality of life and disease course. Various 
CAM techniques such as relaxation and yoga have been employed to address stress and 
anxiety in patients with asthma, however the findings from these studies are inconclusive 
(13, 14).   
 
Meditation is a popular adjunct to traditional therapies. The result from a national survey 
published in 2010 shows that meditation is among the top ten most commonly used CAM 
practices in England (15).  Meditation is defined as an “intentional self-regulation of 
attention from moment to moment” (16). The practice is broadly classified into two major 
groups; concentration meditation (restricting attention to a single point or object) and 
mindfulness meditation (observing sensations, thoughts or emotions without making 
judgements, although this can also involve focusing on the breath) (17). Research has 
demonstrated that meditation can have a positive effect on health and can alter human 
psychological states and physiological states such serum cortisol levels, blood pressure, 
pulse rate and respiratory rate, vital capacity and body temperature (18, 19). The role of 
meditation has been investigated for a wide variety of chronic disease conditions including 
fibromyalgia, cancer and depression (20-22). However, the role of meditation in asthma 
remains critically unevaluated and we are unware of any reviews of existing quantitative 
assessments. This study fills this gap with a comprehensive review and meta-analysis of 
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the effectiveness of meditation on a variety of asthma outcomes, including quality of life, 
pulmonary function, asthma exacerbations, and psychological well-being.  
  
METHODS: The protocol for this systematic review was registered in PROSPERO 
2016:CRD42016038377. The review was conducted and reported following the PRISMA 
(Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines 
(http://www.prisma-statement.org/).  
 
Information sources: We conducted an electronic search to retrieve articles that have 
investigated the effectiveness of meditation on the management of asthma. We searched 
the following electronic bibliographic databases: MEDLINE, EMBASE, CINAHL, PsycINFO 
and AMED. The databases were searched between June and Sept 2016. All references in 
the identified articles were screened for relevant articles.  
 
Eligibility criteria:  Studies were included if (i) they were a randomised controlled trial 
(RCT) involving meditation; (ii) comparison was made with sham therapy, active comparator 
treatment, waiting-list control or usual care; (iii) the study involved adults (≥18 years) with 
asthma. No restriction was put on language or year of publication. Studies of Mindfulness 
Based Stress Reduction (MBSR) were included as although they include three forms of 
practice including yoga, all are taught as different aspects of mindfulness. In contrast, 
studies where meditation was a minor component of other practitioner-based therapies 
(including yoga) without the same emphasis on mindfulness were excluded from the review.  
 
Search: Three search themes were used to interrogate electronic databases: (i) 
identification of the disease i.e. asthma, (ii) identification of CAM therapy i.e. meditation, 
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and (iii) identification of relevant study design, i.e. RCTs. These terms were then combined 
using the Boolean operator AND. The search was based on the Cochrane-suggested 
terminology for asthma, meditation and RCT.  
 
Study selection: Literature search was carried out by two independent researchers (CG 
and RD). Three independent reviewers screened the titles of the articles, and irrelevant and 
duplicate articles were excluded (PP, RD and CG). Abstracts of the relevant articles were 
further screened applying the eligibility criteria and full articles were retrieved. We also 
searched the rgraphies of all selected relevant articles to identify additional relevant 
publications. Any discrepancies relating to eligibility were resolved by discussion with a 
fourth reviewer (HS) to achieve consensus.  
 
Data extraction and items: A descriptive summary table was produced to summarise the 
eligible studies included in the review. The following information was extracted from the 
selected studies: country and publication year, study setting,  patient characteristics (age, 
sex), asthma severity, details of intervention and control, duration of treatment and length of 
follow-up, outcome measures studied, and data on the statistical significance of change of 
outcome measure in the meditation group in relation to control group.   
 
Outcome Measures: The primary outcome was asthma-related quality of life. Secondary 
outcomes of interest were lung function (forced expiratory volume in 1 sec, forced vital 
capacity, peak expiratory flow), asthma symptoms, asthma exacerbation, frequency of 
hospitalisation, use of asthma medication, psychological well-being and safety of meditation 
(drop out because of adverse events or serious adverse events).  
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Assessment of risk of bias in the studies: Two reviewers (PP and CJ) were involved in 
the risk of bias assessment. Risk of bias was assessed using The Cochrane Collaboration 
Tool (Table 8.5.a in the Cochrane Handbook for Systematic Reviews of Interventions, 
version 5.0.0). The tool contains six domains (random sequence generation, allocation 
concealment, blinding of participants and personnel, blinding of outcome assessors, 
incomplete outcome data, selective reporting and other sources of bias). A judgement was 
made regarding the risk of bias for each of these domains using three categories ‘low’, 
‘high’ and ‘unclear’ if the study details were insufficient.   
 
Statistical Analysis: We performed a preliminary narrative synthesis of the data. 
Depending on the heterogeneity of the studies, we performed either a fixed-effect or a 
random effect meta-analysis. Heterogeneity of the trials was assessed through visual 
inspection of forest plots and calculation of the I2 statistic using  a 50% limit to indicate 
substantial heterogeneity (23).  End point scores were expressed as standardised mean 
differences (SMDs) with associated 95% confidence intervals (CIs). We performed the 
meta-analysis using RevMan 5 software (24). We intended to assess the publication bias 
using funnel plot, however, this was not carried out as there were less than 10 studies 
included in our meta-analysis (25).  
 
RESULTS 
 A total of 4193 references were initially identified from the computerized search. After 
removing 362 duplicates, titles of the remaining 3831 articles were screened, 318 abstracts 
were retrieved for further scrutiny, and 28 articles read in full. The four studies meeting the 
inclusion criteria were included in this review (Figure 1). The interrater reliability for abstract 
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screening was moderate (kappa=0.7) between the reviewers (PP and RD). Both reviewers 
had agreement on the final four full text articles that were included in this review.  
 
Characteristics: The study characteristics of the studies are described in Table 1. Two 
studies were conducted in the USA (26, 27), one in Australia (28) and one in India (29).  
Three studies were parallel group RCTs and one was a cross-over RCT. All of the studies 
had one intervention group and one control group. Trial duration varied from 8 weeks to 16 
weeks and follow-up period ranged from 5 months to 12 months.  
 
A total of 196 participants were involved in the analysis of studies included in this review. 
The numbers of eligible and randomly assigned participants and the details of participants 
dropout and adherence were detailed in only two studies (26) (28). The average age of 
participants ranged from 29 to 53 years. One study included equal numbers of male and 
female participants (29). The remaining studies had a higher proportion of female 
participants. The interventions varied greatly between the studies. The first study used a 
Mindfulness Based Stress Reduction (MBSR) programme as an intervention (26), the 
second study used Sahaja yoga meditation, the third used transcendental meditation and 
meditation was used as a control intervention in the fourth study which was evaluating 
breathing exercises [25].  
 
Effect of Interventions: We entered the relevant data and created forest plots. However, 
we were only able to pool the data for asthma-related quality of life, FEV1, and PEF. We 
could not pool data for other outcomes because of divergent outcome measurements and 
insufficient reporting of data. Results are presented below for each outcome, starting with 
the primary outcome of lung function. 
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Asthma Quality of Life: The impact of meditation on disease-specific quality of life was 
assessed in two trials. The trial by Pbert et al (26) used The Juniper Asthma Specific 
Quality of Life Questionnaire (AQLQ-J) comprising 32 items (30) and the trial by Manocha 
(28) used the Sydney  Asthma Specific Quality of Life Questionnaire (AQLQ-S) comprising 
20 items. A pooled result involving 62 intervention and 65 control participants indicated a 
significant improvement in quality of life in the meditation group compared to the control 
group at the end of the study period (SMD 0.40, 95% CI 0.05 to 0.76) (Figure 2).  
 
Lung function: All four studies measured FEV1 and PEF. A pooled analysis of the 
heterogeneous data (I2 = 95%; P value <0.001), including a total of 96 intervention and 100 
control participants, indicated no statistically significant differences in FEV1 between the 
meditation group and the control group at the end of the study period (SMD -0.67, 95% CI -
2.17 to 0.82) (Figure 3). Similarly, a pooled result from the same studies indicated that 
meditation results in no significant improvement in PEF in participants with asthma (SMD -
1.23, 95% CI -3.53 to 1.07) (Figure 4).  
 
Other Outcomes: Asthma symptoms were evaluated in two studies (27, 29), however, the 
data could not be extracted from the first study. The second study which used Pranayama 
breathing exercises as an active intervention and meditation as a control, reported 
significant improvement in FEV1% predicted (88% vs 75%, p<0.001 and number of 
participants reporting symptoms (10% vs 72%, p<0.01) in the relaxation group compared to 
the meditation group. Asthma control, perceived stress, and medication use were measured 
in only one study (26). The study found significant benefit from meditation in perceived 
stress (Perceived Stress Scale score at 12 months 13 vs 16; p<0.001) and medication use 
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(short-term rescue in medication use 2.39 vs 2.49; p <0.001) but no significant 
improvements were reported in asthma control.  
 
Quality of the studies: The quality of the studies varied greatly: one study was rated as 
low risk of bias in six out of seven domains (28), another was rated as high risk for all 
domains (27), the third was rated as low risk for four domains and unclear for allocation 
concealment and blinding (26), the fourth was rated as high risk for four out of seven 
domains(29) (Table 2).  
 
Sensitivity analysis: The two low quality studies (27, 29) did not assess quality of life. We 
conducted a sensitivity analysis for other outcomes (FEV1 and PEF) excluding the low quality 
studies, however, the results did not differ (specifically there was no significant overall 
improvement in FEV1 and PEF observed). The sensitivity analysis also showed that these two 
studies contributed to substantial heterogeneity for the lung function outcomes. The 
heterogeneity for FEV1 was  reduced from 95% to 11% after the exclusion of study by Saxena 
et al (29) and to 0% when both studies were excluded. When same approach was used for 
PEF, I2 value for PEF was reduced from 97% to 83% and then to 0%.  
 
DISCUSSION: This review found some evidence that meditation has beneficial effects on 
improving quality of life in patients with asthma but not on lung function. Results from the 
individual trials suggest that meditation may be helpful in reducing perceived stress and the 
use of short-term rescue medication. Although adherence to meditation was reported in two 
trials (26) (28), none of the trials assessed the safety of the intervention. The independence 
of quality of life improvement from lung function is consistent with the other CAM reviews on 
asthma. Meditation is used as a common component of yoga, and a recently published 
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Cochrane review on the effectiveness of yoga on asthma also found moderate-quality 
evidence that yoga may contribute to small improvements in quality of life and symptoms, 
but not on lung function (31). The findings from our review, however, contradicts with a 
recently published review on mindfulness in respiratory disease (32), which did not find any 
impact of mindfulness on asthma-related quality of life. The review was markedly limited by 
the inclusion of heterogeneous patient groups such as COPD, asthma and other critical 
illnesses requiring mechanical ventilation.    
The exact mechanism on how meditation may work in asthma is unclear. It has been 
reported that meditation may be beneficial in the control and feedback of respiratory 
muscles which come into play during asthma attacks (33). The practice of meditation may 
contribute to a sense of relaxation and a positive mood, helping users to achieve a state of 
mental silence, which is considered to be an innately therapeutic process in managing 
chronic disease like asthma (34). Studies exploring the effects of meditation on the 
autonomous nervous system have reported increased parasympathetic and reduced 
sympathetic nerve activity with increase in overall heart rate variability and cardiorespiratory 
synchronisation (35) (36).This can be supported from the findings of  two studies included in 
this review; one reported substantial reduction in perceived stress (26) and the other 
reported improvement in mood after the practice of meditation (28).   
This is the first review to assess the effectiveness of meditation in asthma. It summarises 
data derived from the RCTs with meta-analysis of their results. We conducted a 
comprehensive literature search without any restriction on date or language. We used a 
pre-specified protocol for trial selection and data extraction however, it must be 
acknowledged that some unpublished trials may have been missed as we did not perform 
the search of grey literature.  Another limitation of this review is the quality of the included 
studies.  Out of four studies, two were of low quality, one was moderate quality and only one 
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was of high quality reporting adequate allocation concealment. Previous reviews have 
reported that lower quality RCTs tend to report a larger effect than high-quality RCTs (37, 
38). As inadequate allocation concealment has been empirically demonstrated to be the 
most important source of bias in RCTs, the findings of our review must be interpreted 
cautiously. The meta-analysis for lung function outcomes (FEV1 and PEF) showed 
substantial heterogeneity due to the inclusion of low quality studies. However, the sensitivity 
analysis showed that although heterogeneity was reduced after the exclusion of poor 
quality studies, there was no change in the direction or size of effect for lung function 
outcomes.  Many outcomes were measured in one study only; limiting the data that could 
be pooled. Also the type of intervention, outcome measure, outcome measurement tool, 
and study duration varied across trials. The aim of the meditative practice is to establish a 
lifelong habit of the meditation, however, three out of four trials failed to assess the long-
term effectiveness of the practice. Our review did not aim to assess the cost-effectiveness 
of the intervention, but none of the studies investigated whether these interventions were 
cost-effective compared to other common interventions in asthma. Exploring cost-
effectiveness of meditation interventions in a future trial would enable assessment of the 
financial consequences of implementing them into routine clinical care. 
In summary, there is a paucity of good quality studies examining the role of meditation in 
asthma. Based on the results of the RCTs included in this review, there is some evidence 
that meditation is beneficial in improving quality of life in asthma patients. As only four 
studies were eligible and two were of poor quality, further trials with better methodological 
quality are needed to support or refute this finding. Variation in measurement tools, 
divergent outcomes and selective reporting in the studies suggest that there is a need to 
standardise outcome measurement tools in asthma. Future trials would benefit from 
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stratifying participants by asthma severity and assessing safety of the intervention to allow 
patients and clinicians to make an informed decision regarding their management plan. 
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Table 1: Characteristics of the included studies 
 
 
Reference, 
country 
Male/ 
Female  
Age  
in 
years  
Asthma 
Severity/ 
control 
 
Study  
setting  
Intervention Group  Control Group 
 
Treatment 
duration, 
follow-up 
 
Outcome 
Pbert et al 
2012, USA 
(26) 
27/56 Mean 
age:53  
Patients 
with mild, 
moderate 
or severe 
asthma 
UMass 
Memorial 
Health care, 
Worcester, 
Massachusetts  
MBSR-weekly 2.5 
hour sessions and an 
all-day 6 hour 
session in the 6th 
week. Participants 
provided with 2 CDs 
containing guided 
instruction for 
mindfulness exercise 
to practice for 
30minutes, 6 
days/week (n=42) 
Healthy Living Course-
lecture and discussion of 
topic related to self-care. 
Behaviour homework 
assigned in consistent 
with  MBSR programme  
(n=41) 
8 weeks, 
follow up at 
12 months 
Difference (+): 
AQOL perceived 
stress, medication 
use 
No difference (-): 
FEV1, PEF, asthma 
control 
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Saxena 2009, 
India (29) 
 
 
25/25 Mean 
(SD) 
29 
(7.5) 
 
Patients 
with 
bronchial 
asthma, 
severity 
not 
reported   
University 
Hospital, 
Ajmar, India 
Breathing 
exercises/pranayama 
-20 minutes twice 
daily (n=25) 
Meditation-20 minutes 
for 12 weeks (n=25) 
12 weeks  Difference (-): FEV1, 
PEFR, asthma 
symptoms 
 
Other outcomes not 
reported  
Manocha 
2002, 
Australia (28) 
21/26 Mean 
age:37 
Patients 
with 
moderate 
or severe 
asthma 
with a 
asthma 
score of at 
least 7 out 
of 12   
Not reported  Participants 
encouraged to 
meditate 10-20 
minutes daily, twice a 
day. Weekly 2 hour 
session involved 
meditation, 
instructional videos, 
personalised 
instructions and 
discussion on 
improving the 
Relaxation method, 
group discussion and 
cognitive behavioural 
therapy. Participants 
encouraged to work on 
relaxation and stress 
management technique 
for 10-20 minutes twice 
daily 
(n=26)  
16 weeks, 
follow-up at 
20 weeks 
Difference (+): None 
No difference (-
):FEV1, FEV1/FVC, 
PEF, AQLQ, 
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experience of 
meditation. (n=21) 
Wilson 1975, 
USA (27) 
9/12 Age 
range 
14-57  
Patients 
with stable 
asthma for 
at least 1 
year 
No reported  Practice 
transcendental 
meditation for 20-30 
minutes daily for 
three months (n=10) 
Read the book  ‘Science 
of being’ and ‘Art of 
living’ by Maharishi 
Mahesh Yogi (n=11) 
3 months, 6 
months 
FEV1, PEFR, 
symptoms measured 
but no inter-group 
comparison reported   
 
19 
 
Table2. Risk of bias summary: author’s judgment about each risk of bias item for each included study 
Reference 
Sequence 
generation 
Allocation 
concealment 
Blinding of 
participants 
and 
personnel  
Blinding 
of 
outcome 
assessor 
Incomplete 
outcome 
data 
Selective 
outcome 
reporting 
Other 
sources 
of bias 
Pbert et al 
2012 (26) + ? ? ? + + + 
Saxena 
2009 (29) + ? ? - - - - 
Manocha 
2002 (28) + + + + ? + + 
Wilson 
1975 (27) - - - - - - - 
+ Low risk of bias, - High risk of bias, ? Unclear 
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Fig 1: Flow chart of article selection process for this review 
Fig 2: Forest plot of comparison: Meditation versus Control, outcome: Asthma-related 
Quality of Life  
Fig 3: Forest plot of comparison: Meditation versus Control, outcome: FEV1  
Fig 4: Forest plot of comparison: Meditation versus Control, outcome: PEF 
 
 
 
 
 
 
 
